BI-847325

产品名称：BI-847325

BI-847325生物活性：

BI-847325 is an orally bioavailable, and selective dual MEK/Aurora kinase inhibitor with IC50 of 3 nM, 25 nM, 15 nM, 25 nM, and 4 nM for Xenopus laevis Aurora B, human Aurora A and Aurora C, as well as human MEK1 and MEK2, respectively. Phase 1.

BI-847325制备储备液：

浓度溶解体积质量	1mg	5mg	10mg
1mM	2.1032mL	10.5159mL	21.0318mL
5mM	0.4206mL	2.1032mL	4.2064mL
10mM	0.2103mL	1.0516mL	2.1032mL
50mM	0.0421mL	0.2103mL	0.4206mL

BI-847325临床数据( 数据源于：http:// clinicaltrials.gov）

Conversion of different model animals based on BSA（Value based on data from FDA Draft Guidelines）


   Animal A (mg/kg)=Animal B（mg/kg）multiplied by    AnimalBm系数/AnimalAm系数
   For example, to modify the dose of resveratrol uesd for a mouse(22.4mg/kg) to a dose based on the BSA for a rat, multiply 22.4mg/kg by the Km factor for a mouse and zhen divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2mg/kg


   南京赛泓瑞生物科技有限公司是专业从事生化试剂、分子生物学试剂、实验耗材及实验仪器研发、销售、服务为一体的专业性生物科技公司。本着服务科学的理念，赛泓瑞建立了生命科学研究工具的研发、生产、销售及技术服务平台，现已有数万余种产品，并每年不断开发新产品，为广大的生命科学研究人员、医学、药学、农业、环保等的科研人员提供科研工具性产品及技术服务.
经营范围：抑制剂、ELISA试剂盒、原代细胞和细胞株、化学试剂、蛋白、抗体、分子试剂和试剂盒。